Search hospitals > Hawaii > Honolulu
Queen's Cancer Center - Kuakini
Claim this profileHonolulu, Hawaii 96813
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
222 reported clinical trials
15 medical researchers
Summary
Queen's Cancer Center - Kuakini is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Cancer, Lung Cancer, Breast cancer and other specialties. Queen's Cancer Center - Kuakini is involved with conducting 222 clinical trials across 349 conditions. There are 15 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Michael Carney, MD, and Jami A. Fukui.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
ER positive
HER2 positive
Top PIs
Jeffrey L. BerenbergStraub Clinic and Hospital1 year of reported clinical research
Expert in Lung Cancer
Expert in Parotid Gland Cancer
29 reported clinical trials
77 drugs studied
Jared D. AcobaQueen's Medical Center2 years of reported clinical research
Studies Cervical Adenocarcinoma
Studies Parotid Gland Cancer
18 reported clinical trials
38 drugs studied
Michael Carney, MDKapiolani Medical Center for Women and Children5 years of reported clinical research
Expert in Ovarian Cancer
Studies Parotid Gland Cancer
14 reported clinical trials
29 drugs studied
Jami A. FukuiKapiolani Medical Center for Women and Children5 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
14 reported clinical trials
35 drugs studied
Clinical Trials running at Queen's Cancer Center - Kuakini
Breast Cancer
Lung Cancer
Cancer
Ovarian Cancer
Parotid Gland Cancer
Breast cancer
Non-Small Cell Lung Cancer
Esophageal cancer
Pancreatic Carcinoma
Laryngeal Cancer
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Queen's Cancer Center - Kuakini?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.